Recent events

Every US listed company has to file a Form 8-K within four business days of something significant happening, and tag it with the item number that says what kind of thing it was. This is that feed, over the last 180 days - the filings themselves, on EDGAR, one click away. Nothing here is a summary of what a filing said; it is what the company told SEC it was filing about.

Every 8-K item filed, including the routine ones - earnings dates, shareholder votes and Regulation FD disclosures. Not the exhibit lists.

Date Company Event Filing
AMERICAN EXPRESS CO AXP Charter or fiscal year changed Item 5.03 Form 8-K
AMERICAN EXPRESS CO AXP Other event Item 8.01 Form 8-K
ASHFORD HOSPITALITY TRUST INC AHT Results announced Item 2.02 Form 8-K
Acrivon Therapeutics, Inc. ACRV Results announced Item 2.02 Form 8-K
Acumen Pharmaceuticals, Inc. ABOS Results announced Item 2.02 Form 8-K
Acumen Pharmaceuticals, Inc. ABOS Regulation FD disclosure Item 7.01 Form 8-K
Airsculpt Technologies, Inc. AIRS Other event Item 8.01 Form 8-K
Alkermes plc. ALKS Material agreement signed Item 1.01 Form 8-K
Allogene Therapeutics, Inc. ALLO Results announced Item 2.02 Form 8-K
Altimmune, Inc. ALT Results announced Item 2.02 Form 8-K
Alto Neuroscience, Inc. ANRO Results announced Item 2.02 Form 8-K
Amcor plc AMCR Results announced Item 2.02 Form 8-K
American Healthcare REIT, Inc. AHR Other event Item 8.01 Form 8-K
American Strategic Investment Co. NYC Results announced Item 2.02 Form 8-K
American Strategic Investment Co. NYC Regulation FD disclosure Item 7.01 Form 8-K
AmpliTech Group, Inc. AMPG Material agreement signed Item 1.01 Form 8-K
Andersen Group Inc. ANDG Results announced Item 2.02 Form 8-K
Andersen Group Inc. ANDG Regulation FD disclosure Item 7.01 Form 8-K
Annexon, Inc. ANNX Results announced Item 2.02 Form 8-K
Annexon, Inc. ANNX Other event Item 8.01 Form 8-K
Anteris Technologies Global Corp. AVR Results announced Item 2.02 Form 8-K
Apollo Global Management, Inc. APO Shareholder vote Item 5.07 Form 8-K
Applied Aerospace & Defense, Inc. AADX Results announced Item 2.02 Form 8-K
Aprea Therapeutics, Inc. APRE Results announced Item 2.02 Form 8-K
Aprea Therapeutics, Inc. APRE Other event Item 8.01 Form 8-K
Aptera Motors Corp SEV Results announced Item 2.02 Form 8-K
Aptera Motors Corp SEV Regulation FD disclosure Item 7.01 Form 8-K
Arbutus Biopharma Corp ABUS Results announced Item 2.02 Form 8-K
Archer-Daniels-Midland Co ADM Officer or director change Item 5.02 Form 8-K
Armata Pharmaceuticals, Inc. ARMP Results announced Item 2.02 Form 8-K
ArriVent BioPharma, Inc. AVBP Material agreement signed Item 1.01 Form 8-K
ArriVent BioPharma, Inc. AVBP Results announced Item 2.02 Form 8-K
Arrive AI Inc. ARAI Debt acceleration or default Item 2.04 Form 8-K
Arrive AI Inc. ARAI Officer or director change Item 5.02 Form 8-K
Atara Biotherapeutics, Inc. ATRA Results announced Item 2.02 Form 8-K
Atea Pharmaceuticals, Inc. AVIR Results announced Item 2.02 Form 8-K
Avalyn Pharma Inc. AVLN Results announced Item 2.02 Form 8-K
Azitra, Inc. AZTR Results announced Item 2.02 Form 8-K
BARNWELL INDUSTRIES INC BRN Results announced Item 2.02 Form 8-K
BATTALION OIL CORP BATL Results announced Item 2.02 Form 8-K

Item numbers are Form 8-K's own. An 8-K says that a company filed about something, not what it decided - a management change under item 5.02 covers both a routine board retirement and a chief executive being removed, and only the filing tells you which. Dates are filing dates: an 8-K is due within four business days of the event, so the event itself is up to a week earlier. Events are collected from each company's SEC submissions index, which reaches back roughly a thousand filings - for a company that files often, that is less than three years.